Pharmafile Logo
Pharmafocus logo
Advanced Search

Pan appoints trio of new starters

September 9, 2011
Medical Communications appointment, medical communications

Pan Advertising has appointed a trio of new starters across its creative and client services teams. Maneesh Sharma joins the …

Appointment
1hq_burton_paul

Branding agency 1HQ appoints Burton Paul

September 9, 2011
Medical Communications appointment, medical communications

Burton Paul has joined Windsor, UK-based branding agency 1HQ as client director to head up their health division. He has …

Appointment

EMA grants first paediatric use marketing authorisation

September 9, 2011
Sales and Marketing Buccolam, PUMA, Viropharma, paediatric trials, seizures

The first children’s medicine to hold a new paediatric use marketing authorisation (PUMA), making it available for children only, has …

News
Zytiga

European approval for prostate cancer drug Zytiga

September 8, 2011
Sales and Marketing Janssen, Jevtana, Johnson & Johnson, Zytiga, prostate cancer

Johnson & Johnson’s Zytiga has been approved in the EU for late-stage prostate cancer. Zytiga (abiraterone acetate) is now licenced …

News
Novartis

Everolimus approved to treat rare tumour disease

September 8, 2011
Sales and Marketing Novartis, SEGA, Votubia, everolimus

Novartis has gained EU approval for everolimus to be used to treat a rare non-cancerous tumour. Everolimus is already marketed …

News

New ABPI chief executive to focus on industry reputation

September 8, 2011
Research and Development, Sales and Marketing ABPI, industry relations

The new chief executive of the ABPI used his first public speech to focus on the reputation of the pharma …

News

Sanofi banks on personalised medicine for growth

September 8, 2011
Sales and Marketing Genzyme, Sanofi

Sanofi has nailed its colours to the mast of personalised medicine, banking on the purchase of US biotech company Genzyme, …

News

Algeta appoints first head of comms and investor relations

September 8, 2011
Medical Communications, Research and Development appointment, medical communications, research and development

Norwegian biotech Algeta has appointed Dr Mike Booth to the newly-created role of senior VP of communications and corporate affairs. …

Appointment

Dendreon drops GSK as Provenge manufacturing partner

September 8, 2011
Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news

Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …

News
Enbrel

Forecasting future launch success

September 8, 2011
Sales and Marketing Champix, Enbrel, forecast planning, forecasting

Pharmaceutical companies are moving into new and sometimes very different (often specialised) therapy areas, because of global market conditions and …

Feature

Clinical research news in brief

September 8, 2011
Research and Development research and development news

This roundup includes using social media to recruit trial subjects, a strategic level service deal between BMS and Icon, plus …

News

Eisai shares risk with novel trial funding approach

September 7, 2011
Research and Development Eisai, clinical trials, research and development news

Eisai has unveiled a novel risk-sharing approach to accelerate its late-stage research programme by accepting new sources of clinical trial …

News

Battle over health reform begins again

September 7, 2011
Health and Social Care Bill, NHS, NHS reforms

The battle over the future of the NHS has began again as the Health and Social Care Bill yesterday returned …

News

NICE recommends Takeda’s cancer drug Mepact

September 7, 2011
Sales and Marketing Mepact, NICE, Takeda

NICE has reversed its stance on Mepact and recommended the bone cancer drug after re-examining discounts and a new patient …

News
EMA

EMA should compare ‘like-for-like’ when assessing new drugs

September 7, 2011
Research and Development EMA, clnical trials, research and development news

The European system of comparing drugs against placebo and not against a comparator is flawed, according to a new LSE …

News

Sanofi’s Multaq in the dock

September 7, 2011
Sales and Marketing Multaq, Sanofi

The EMA will later this month decide whether Sanofi’s Multaq can remain on the market after reports emerged of serious …

News

AZ’s Nexium faces generic competition in the UK

September 6, 2011
Nexium, Ranbaxy, generics

Generic specialist Ranbaxy has launched its version of AstraZeneca’s anti-ulcer blockbuster Nexium in the UK. It will be available in …

News

Lilly considering a stake in Turkish drugmaker

September 6, 2011
Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news

Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …

News

New API production process ‘could transform pharma’

September 6, 2011
Manufacturing and Production pharma manufacturing news, pharma production

UK researchers have started work on a new project to examine a new production method that they claim could “significantly …

News
Roche

Roche and Evotec to develop Alzheimer’s drug

September 6, 2011
Alzheimer's disease, Evotec, Roche

Roche and Evotec are to collaborate on the development and commercialisation of Evotec’s MAO-B inhibitor in patients with Alzheimer’s disease. …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026